Literature DB >> 8262631

Toxoplasma encephalitis in congenic B10 and BALB mice: impact of genetic factors on the immune response.

M Deckert-Schlüter1, D Schlüter, D Schmidt, G Schwendemann, O D Wiestler, H Hof.   

Abstract

Factors which determine the pathogenesis and course of Toxoplasma encephalitis are poorly understood. In the present study, the influence of genetic factors in congenic B10 and BALB mice of H-2q, H-2k, and H-2b haplotypes was examined following oral infection with a low-virulence strain of Toxoplasma gondii (DX). There were striking differences among these strains. Whereas B10 mice were highly susceptible, BALB mice had a less severe and more protracted disease. In all animals with a fatal outcome, Toxoplasma encephalitis was the cause of death. Within the two congenic groups, the major histocompatibility complex haplotype had a strong impact on the disease. The H-2k haplotype was associated with early death in B10 mice but with a favorable outcome in BALB mice, whereas the reverse was observed for the H-2q haplotype. These findings indicate that genetically determined factors are critically involved in determining the intracerebral immune response and the course of murine toxoplasmosis. Some of these factors appear to be associated with the major histocompatibility complex haplotype, but significant differences between B10 and BALB mice point to a modulating role of additional genetic loci. Immunohistochemical studies and cytokine analyses of cerebrospinal fluid and serum revealed significant differences in the intracerebral immune response between susceptible and resistant strains. A poor outcome was associated with a large number of intracerebral parasites, significant tissue necrosis, a reduced number of intracerebral CD4+ T cells, low intrathecal tumor necrosis factor levels, and, to a lesser extent, a reduced number of intracerebral CD8+ T cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8262631      PMCID: PMC186090          DOI: 10.1128/iai.62.1.221-228.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  38 in total

1.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

2.  Susceptibility to chronic infection with Toxoplasma gondii does not correlate with susceptibility to acute infection in mice.

Authors:  Y Suzuki; M A Orellana; S Y Wong; F K Conley; J S Remington
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

3.  F4/80, a monoclonal antibody directed specifically against the mouse macrophage.

Authors:  J M Austyn; S Gordon
Journal:  Eur J Immunol       Date:  1981-10       Impact factor: 5.532

4.  A protective role for endogenous tumor necrosis factor in Toxoplasma gondii infection.

Authors:  L L Johnson
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

5.  B220: a B cell-specific member of th T200 glycoprotein family.

Authors:  R L Coffman; I L Weissman
Journal:  Nature       Date:  1981-02-19       Impact factor: 49.962

6.  Immune response of mice to ingested Toxoplasma gondii: a model of toxoplasma infection acquired by ingestion.

Authors:  R McLeod; R G Estes; D G Mack; H Cohen
Journal:  J Infect Dis       Date:  1984-02       Impact factor: 5.226

7.  Strain-dependent differences in murine susceptibility to toxoplasma.

Authors:  F G Araujo; D M Williams; F C Grumet; J S Remington
Journal:  Infect Immun       Date:  1976-05       Impact factor: 3.441

8.  A shared alloantigenic determinant on Ia antigens encoded by the I-A and I-E subregions: evidence for I region gene duplication.

Authors:  A Bhattacharya; M E Dorf; T A Springer
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

9.  Monoclonal xenogeneic antibodies to murine cell surface antigens: identification of novel leukocyte differentiation antigens.

Authors:  T Springer; G Galfrè; D S Secher; C Milstein
Journal:  Eur J Immunol       Date:  1978-08       Impact factor: 5.532

10.  Genetic control of murine resistance to Toxoplasma gondii.

Authors:  D M Williams; F C Grumet; J S Remington
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

View more
  25 in total

1.  PD-1-mediated attrition of polyfunctional memory CD8+ T cells in chronic toxoplasma infection.

Authors:  Rajarshi Bhadra; Jason P Gigley; Imtiaz A Khan
Journal:  J Infect Dis       Date:  2012-04-26       Impact factor: 5.226

2.  The Toxoplasma gondii peptide AS15 elicits CD4 T cells that can control parasite burden.

Authors:  Harshita Satija Grover; Nicolas Blanchard; Federico Gonzalez; Shiao Chan; Ellen A Robey; Nilabh Shastri
Journal:  Infect Immun       Date:  2012-07-09       Impact factor: 3.441

3.  Organ- and disease-stage-specific regulation of Toxoplasma gondii-specific CD8-T-cell responses by CD4 T cells.

Authors:  Sonja Lütjen; Sabine Soltek; Simona Virna; Martina Deckert; Dirk Schlüter
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

4.  Control of Toxoplasma reactivation by rescue of dysfunctional CD8+ T-cell response via PD-1-PDL-1 blockade.

Authors:  Rajarshi Bhadra; Jason P Gigley; Louis M Weiss; Imtiaz A Khan
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-16       Impact factor: 11.205

Review 5.  Toxoplasma gondii and ocular toxoplasmosis: pathogenesis.

Authors:  C E Pavesio; S Lightman
Journal:  Br J Ophthalmol       Date:  1996-12       Impact factor: 4.638

6.  Microsatellite in the beta-tubulin gene of Toxoplasma gondii as a new genetic marker for use in direct screening of amniotic fluids.

Authors:  J M Costa; M L Dardé; B Assouline; M Vidaud; S Bretagne
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

7.  Toxoplasma: Immunity and Pathogenesis.

Authors:  Imtiaz A Khan; Charlotte Ouellette; Keer Chen; Magali Moretto
Journal:  Curr Clin Microbiol Rep       Date:  2019-02-04

8.  Unconventional Peptide Presentation by Major Histocompatibility Complex (MHC) Class I Allele HLA-A*02:01: BREAKING CONFINEMENT.

Authors:  Soumya G Remesh; Massimo Andreatta; Ge Ying; Thomas Kaever; Morten Nielsen; Curtis McMurtrey; William Hildebrand; Bjoern Peters; Dirk M Zajonc
Journal:  J Biol Chem       Date:  2017-02-08       Impact factor: 5.157

9.  Molecular markers of susceptibility to ocular toxoplasmosis, host and guest behaving badly.

Authors:  Adriana Lima Vallochi; Anna Carla Goldberg; Angela Falcai; Rajendranath Ramasawmy; Jorge Kalil; Cláudio Silveira; Rubens Belfort; Luiz Vicente Rizzo
Journal:  Clin Ophthalmol       Date:  2008-12

10.  Dynamics of the intracerebral and splenic cytokine mRNA production in Toxoplasma gondii-resistant and -susceptible congenic strains of mice.

Authors:  M Deckert-Schlüter; S Albrecht; H Hof; O D Wiestler; D Schlüter
Journal:  Immunology       Date:  1995-07       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.